What if US Commercial Real Estate Fails? An Analysis on Potential Contagion Effects
Quality will triumph volatility. China equities started the year on solid ground but surrendered its stellar performance and trailed that of global equities (Figure 1). Year-to-date (YTD), China equi...
Chief Investment Office - Hong Kong23 May 2023
  • Slowing export momentum, tensions in North Asia, and uneven macro data readings have dampened YTD China equity index performance
  • Share prices of China large banks and insurance companies however, performed well over the past few months supported by their yields and earnings growth, respectively
  • The proposed split of Alibaba into separate operating units has set a precedent for the sector to crystalise the embedded value in the moat-like conglomerate structure
  • We advocate staying invested in select themes in China adhering to our Barbell strategy of taking outsized positions in equities with attractive yields on one end and secular growth on the other
Article image
Photo credit: AFP Photo
Read More

Quality will triumph volatility. China equities started the year on solid ground but surrendered its stellar performance and trailed that of global equities (Figure 1). Year-to-date (YTD), China equity index is flat compared to nearly 9% returns recorded by global equities. Some of the catalysts have taken longer than expected to materialise.

Among the headwinds surrounding China equities are slowing export momentum, tensions in the North Asia region, and uneven macro data readings. Nonetheless, we maintain the view that the performance of selected China-centric sectors should turn out well, as the momentum post reopening gains pace and market dislocation reverses.


Figure 1: China and global equities (Normalised)


Our ongoing constructive stance on China focuses on the following themes and adheres to our CIO Barbell Strategy framework. On the income side, we prefer China large state banks which reward investors with continuous and attractive yields. On the growth side, we continue to favour the insurance sector and large technology platform companies that have demonstrated solid profit track records. They are also beneficiaries of consumption recovery riding on the reopening momentum.

Favour large state-owned banks. China financials have delivered good share price performance since the conclusion of China’s Party Congress and have further extended their gains YTD. China insurance and the broad financial sector returned 60% and 35% respectively since end of October 2022 (Figure 2), with YTD gains of c.10% driven by:

1. Expectations of US rate hikes coming to an end. This development should reverse the yield compression between China large banks and bonds
2. Narrowing of steep valuation discounts
3. Resumption in total social financing growth to 11.7%, back to the level last seen in January 2022
4. Sustainable dividend yields and the appeal of total returns (Figure 3)


Figure 2: Performance of China financials and insurance sectors (Normalised)



Figure 3: The importance of total returns (Normalised)



Constructive on China’s insurance sector. We are constructive on China’s insurance sector owing to its fundamental importance to the vast population, promising operating environment, and growth outlook. Life insurance annual premium reached CNY2.5t at the end of 2021, delivering an impressive CAGR of 10% between 2012 and 2021 (Figure 4).
Another supportive driver is the low life insurance penetration in China which was merely 2.2% of GDP as of 2021, considerably lower than those of other markets such as Hong Kong (20.5%), America (12.4%), Singapore (11.4%), and OECD countries (9.4%). Upside potential for the sector’s revenue and profits in the coming years remains encouraging as life insurance penetration in China accelerates.


Figure 4: Upside to insurance penetration



Notwithstanding their recent outperformance, China insurers are trading at 6x forward earnings (Figure 5), which is not demanding at all. The sector’s revenue and profitability have stayed robust and remained unscathed over the past few years. The divergence between the sector’s market capitalisation and total addressable market is also unwarranted. Between 2009 and 2019, the sector’s market capitalisation-to-total premiums was at the range of 1.5x to 2.0x but this ratio has declined to 1.0x since 2021 (Figure 6). We believe China insurance stocks will be rerated up from current levels.


Figure 5: Valuations at multi-year low



Figure 6: Divergence between market capitalisation and total addressable market



China digital platform companies lagging. The performance of China’s technology sector has not panned out as we expected, owing mainly to ongoing policy uncertainties which have dampened sentiment and share price performances.
Given the moat-like structure and resilience in earnings, the sector’s share price weakness is unjustified (Figure 7). There are obvious bifurcations in share price performances among industry players where sector leaders with consistent profitability and solid earnings growth are trading at reasonable valuations in contrast to less profitable or loss-making peers.


Figure 7: Weakness in China Internet unjustified


The proposed splitting and listing of operating units by Alibaba sets a precedent for the sector, which would ultimately see the moat-like divisions realise value and free the holding company of its “conglomerate discount”. The split will also offer investors more targeted investment choices, be it advanced technology or digital commerce.
Given existing trade restrictions and slowing external demand, China’s government is incentivised to expedite the development of its already deep domestic and technology supply chain.
Support for the long term. We expect more resources to be allocated and policy support across verticals to accelerate the recovery in China’s domestic consumption, support for the banking system, and advancement of the digital roadmap in the march towards self-sufficiency.

Topic

Disclaimers and Important Notices

The information published by DBS Bank Ltd. (company registration no.: 196800306E) (“DBS”) is for information only. It is based on information or opinions obtained from sources believed to be reliable (but which have not been independently verified by DBS, its related companies and affiliates (“DBS Group”)) and to the maximum extent permitted by law, DBS Group does not make any representation or warranty (express or implied) as to its accuracy, completeness, timeliness or correctness for any particular purpose. Opinions and estimates are subject to change without notice. The publication and distribution of the information does not constitute nor does it imply any form of endorsement by DBS Group of any person, entity, services or products described or appearing in the information. Any past performance, projection, forecast or simulation of results is not necessarily indicative of the future or likely performance of any investment or securities. Foreign exchange transactions involve risks. You should note that fluctuations in foreign exchange rates may result in losses. You may wish to seek your own independent financial, tax, or legal advice or make such independent investigations as you consider necessary or appropriate.

The information published is not and does not constitute or form part of any offer, recommendation, invitation or solicitation to subscribe to or to enter into any transaction; nor is it calculated to invite, nor does it permit the making of offers to the public to subscribe to or enter into any transaction in any jurisdiction or country in which such offer, recommendation, invitation or solicitation is not authorised or to any person to whom it is unlawful to make such offer, recommendation, invitation or solicitation or where such offer, recommendation, invitation or solicitation would be contrary to law or regulation or which would subject DBS Group to any registration requirement within such jurisdiction or country, and should not be viewed as such. Without prejudice to the generality of the foregoing, the information, services or products described or appearing in the information are not specifically intended for or specifically targeted at the public in any specific jurisdiction.

The information is the property of DBS and is protected by applicable intellectual property laws. No reproduction, transmission, sale, distribution, publication, broadcast, circulation, modification, dissemination, or commercial exploitation such information in any manner (including electronic, print or other media now known or hereafter developed) is permitted.

DBS Group and its respective directors, officers and/or employees may have positions or other interests in, and may effect transactions in securities mentioned and may also perform or seek to perform broking, investment banking and other banking or financial services to any persons or entities mentioned.

To the maximum extent permitted by law, DBS Group accepts no liability for any losses or damages (including direct, special, indirect, consequential, incidental or loss of profits) of any kind arising from or in connection with any reliance and/or use of the information (including any error, omission or misstatement, negligent or otherwise) or further communication, even if DBS Group has been advised of the possibility thereof.

The information is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation. The information is distributed (a) in Singapore, by DBS Bank Ltd.; (b) in China, by DBS Bank (China) Ltd; (c) in Hong Kong, by DBS Bank (Hong Kong) Limited; (d) in Taiwan, by DBS Bank (Taiwan) Ltd; (e) in Indonesia, by PT DBS Indonesia; and (f) in India, by DBS Bank Ltd, Mumbai Branch.